Last 12 months
Inside the activity.
10 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 4 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 5 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2017 Filed Sep 1, 2017 20:10 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
SaleCommon Stock | 10,104 | $27.46 | $277,475.04 |
DisclosureSEC source: 0001225208-17-014468 · doc4.xml · nonDerivative · entry 1 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,742 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at $27.40 and $27.525. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 01, 2017 Filed Jul 2, 2018 20:28 UTC |
Sununu John EDirector
|
PurchaseCommon Stock | 13 | $27.50 | $357.50 |
DisclosureSEC source: 0001225208-18-011026 · doc4.xml · nonDerivative · entry 3 Sununu John E · CIK 0001458974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,337 F1 · kind: These shares were acquired by, and held in, a managed account. F2 · balance_after: Reflects transactions that have taken place since the date of this transaction and which have been previously reported on Form 4. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.39 | $0.00 |
DisclosureSEC source: 0001225208-17-014467 · doc4.xml · derivative · entry 12 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,035 Underlying: Common Stock · 10,000 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.41 | $0.00 |
DisclosureSEC source: 0001225208-17-014467 · doc4.xml · derivative · entry 11 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,231 Underlying: Common Stock · 20,000 shares Expires 2020-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Grant to the reporting person of an option to purchase 48,231 shares of common stock vesting in four annual increments beginning on February 16, 2011, the first anniversary of the grant. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
SaleCommon Stock | 30,000 | $27.45 | $823,539.00 |
DisclosureSEC source: 0001225208-17-014467 · doc4.xml · nonDerivative · entry 7 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,233 F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.45 to $27.465, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionCommon Stock | 10,000 | $7.39 | $73,900.00 |
DisclosureSEC source: 0001225208-17-014467 · doc4.xml · nonDerivative · entry 6 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionCommon Stock | 20,000 | $7.41 | $148,200.00 |
DisclosureSEC source: 0001225208-17-014467 · doc4.xml · nonDerivative · entry 5 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 30, 2017 Filed Sep 1, 2017 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,031 | $0.00 Strike: $6.28 | $0.00 |
DisclosureSEC source: 0001225208-17-014467 · doc4.xml · derivative · entry 10 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,031 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant. Read SEC document |
| August 30, 2017 Filed Sep 1, 2017 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.41 | $0.00 |
DisclosureSEC source: 0001225208-17-014467 · doc4.xml · derivative · entry 9 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,231 Underlying: Common Stock · 10,000 shares Expires 2020-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Grant to the reporting person of an option to purchase 48,231 shares of common stock vesting in four annual increments beginning on February 16, 2011, the first anniversary of the grant. Read SEC document |
| August 30, 2017 Filed Sep 1, 2017 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $12.52 | $0.00 |
DisclosureSEC source: 0001225208-17-014467 · doc4.xml · derivative · entry 8 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,568 Underlying: Common Stock · 10,000 shares Expires 2018-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase 25,568 shares of common stock vesting in four annual increments beginning on February 12, 2009, the first anniversary of the grant. Read SEC document |
| August 30, 2017 Filed Sep 1, 2017 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
SaleCommon Stock | 27,031 | $27.08 | $732,083.28 |
DisclosureSEC source: 0001225208-17-014467 · doc4.xml · nonDerivative · entry 4 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,233 F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at $27.08 and $27.09. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 30, 2017 Filed Sep 1, 2017 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionCommon Stock | 7,031 | $6.28 | $44,154.68 |
DisclosureSEC source: 0001225208-17-014467 · doc4.xml · nonDerivative · entry 3 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 30, 2017 Filed Sep 1, 2017 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionCommon Stock | 10,000 | $7.41 | $74,100.00 |
DisclosureSEC source: 0001225208-17-014467 · doc4.xml · nonDerivative · entry 2 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 30, 2017 Filed Sep 1, 2017 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionCommon Stock | 10,000 | $12.52 | $125,200.00 |
DisclosureSEC source: 0001225208-17-014467 · doc4.xml · nonDerivative · entry 1 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 20:10 UTC |
Phalen Michael P.EVP & President, MedSurg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,500 | $0.00 Strike: $7.16 | $0.00 |
DisclosureSEC source: 0001225208-17-014413 · doc4.xml · derivative · entry 3 Phalen Michael P. · CIK 0001483882 · EVP & President, MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,335 Underlying: Common Stock · 15,500 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 20:10 UTC |
Phalen Michael P.EVP & President, MedSurg
|
SaleCommon Stock | 15,500 | $26.87 | $416,559.40 |
DisclosureSEC source: 0001225208-17-014413 · doc4.xml · nonDerivative · entry 2 Phalen Michael P. · CIK 0001483882 · EVP & President, MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,666 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.865 to $26.895, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 29, 2017 Filed Aug 30, 2017 20:10 UTC |
Phalen Michael P.EVP & President, MedSurg
|
Exercise / conversionCommon Stock | 15,500 | $7.16 | $110,980.00 |
DisclosureSEC source: 0001225208-17-014413 · doc4.xml · nonDerivative · entry 1 Phalen Michael P. · CIK 0001483882 · EVP & President, MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 03, 2017 Filed Aug 4, 2017 20:10 UTC |
Carruthers WendySVP, Human Resources
|
SaleCommon Stock | 12,433 | $26.75 | $332,583.99 |
DisclosureSEC source: 0001225208-17-013301 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,253 F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 20:10 UTC |
Sorenson John BradleySVP, Manuf & Sup Chn
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $13.08 | $0.00 |
DisclosureSEC source: 0001225208-17-013300 · doc4.xml · derivative · entry 7 Sorenson John Bradley · CIK 0001629277 · SVP, Manuf & Sup Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 2,500 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 20:10 UTC |
Sorenson John BradleySVP, Manuf & Sup Chn
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,600 | $0.00 Strike: $16.31 | $0.00 |
DisclosureSEC source: 0001225208-17-013300 · doc4.xml · derivative · entry 6 Sorenson John Bradley · CIK 0001629277 · SVP, Manuf & Sup Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,951 Underlying: Common Stock · 2,600 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 20:10 UTC |
Sorenson John BradleySVP, Manuf & Sup Chn
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,800 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001225208-17-013300 · doc4.xml · derivative · entry 5 Sorenson John Bradley · CIK 0001629277 · SVP, Manuf & Sup Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,387 Underlying: Common Stock · 2,800 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 20:10 UTC |
Sorenson John BradleySVP, Manuf & Sup Chn
|
SaleCommon Stock | 7,900 | $26.37 | $208,327.74 |
DisclosureSEC source: 0001225208-17-013300 · doc4.xml · nonDerivative · entry 4 Sorenson John Bradley · CIK 0001629277 · SVP, Manuf & Sup Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,880 F1 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at $26.3702 and $26.372. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 20:10 UTC |
Sorenson John BradleySVP, Manuf & Sup Chn
|
Exercise / conversionCommon Stock | 2,500 | $13.08 | $32,700.00 |
DisclosureSEC source: 0001225208-17-013300 · doc4.xml · nonDerivative · entry 3 Sorenson John Bradley · CIK 0001629277 · SVP, Manuf & Sup Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 20:10 UTC |
Sorenson John BradleySVP, Manuf & Sup Chn
|
Exercise / conversionCommon Stock | 2,600 | $16.31 | $42,406.00 |
DisclosureSEC source: 0001225208-17-013300 · doc4.xml · nonDerivative · entry 2 Sorenson John Bradley · CIK 0001629277 · SVP, Manuf & Sup Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 20:10 UTC |
Sorenson John BradleySVP, Manuf & Sup Chn
|
Exercise / conversionCommon Stock | 2,800 | $17.26 | $48,328.00 |
DisclosureSEC source: 0001225208-17-013300 · doc4.xml · nonDerivative · entry 1 Sorenson John Bradley · CIK 0001629277 · SVP, Manuf & Sup Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 20:06 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
SaleCommon Stock | 10,000 | $26.67 | $266,650.00 |
DisclosureSEC source: 0001225208-17-013151 · doc4.xml · nonDerivative · entry 1 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,846 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.649 to $26.6809, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 20:50 UTC |
Sorenson John BradleySVP, Manuf & Sup Chn
|
SaleCommon Stock | 2,100 | $27.15 | $57,015.00 |
DisclosureSEC source: 0001225208-17-013085 · doc4.xml · nonDerivative · entry 1 Sorenson John Bradley · CIK 0001629277 · SVP, Manuf & Sup Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,880 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 20:49 UTC |
Phalen Michael P.EVP & President, MedSurg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,500 | $0.00 Strike: $7.16 | $0.00 |
DisclosureSEC source: 0001225208-17-013084 · doc4.xml · derivative · entry 3 Phalen Michael P. · CIK 0001483882 · EVP & President, MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,835 Underlying: Common Stock · 15,500 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 20:49 UTC |
Phalen Michael P.EVP & President, MedSurg
|
SaleCommon Stock | 15,500 | $27.13 | $420,541.35 |
DisclosureSEC source: 0001225208-17-013084 · doc4.xml · nonDerivative · entry 2 Phalen Michael P. · CIK 0001483882 · EVP & President, MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,919 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.121 to $27.15, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 20:49 UTC |
Phalen Michael P.EVP & President, MedSurg
|
Exercise / conversionCommon Stock | 15,500 | $7.16 | $110,980.00 |
DisclosureSEC source: 0001225208-17-013084 · doc4.xml · nonDerivative · entry 1 Phalen Michael P. · CIK 0001483882 · EVP & President, MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,572 | $0.00 Strike: $7.39 | $0.00 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · derivative · entry 15 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,716 Underlying: Common Stock · 7,572 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F9 · derivative.exercise_date: Grant to the reporting person of an option to purchase 37,860 shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the grant. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,422 | $0.00 Strike: $7.16 | $0.00 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · derivative · entry 14 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,268 Underlying: Common Stock · 12,422 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F8 · derivative.exercise_date: Grant to the reporting person of an option to purchase 62,112 shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,093 | $0.00 Strike: $6.28 | $0.00 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · derivative · entry 13 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,280 Underlying: Common Stock · 6,093 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F7 · derivative.exercise_date: Grant to the reporting person of an option to purchase 30,466 shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the grant. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,661 | $0.00 Strike: $13.08 | $0.00 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · derivative · entry 12 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,645 Underlying: Common Stock · 13,661 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F6 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock in four equal annual installments beginning on February 24, 2015, the first anniversary of the grant. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,086 | $0.00 Strike: $16.31 | $0.00 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · derivative · entry 11 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,345 Underlying: Common Stock · 15,086 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F5 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the grant. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,863 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · derivative · entry 10 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,454 Underlying: Common Stock · 16,863 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the grant. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,461 | $0.00 Strike: $7.41 | $0.00 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · derivative · entry 9 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,386 Underlying: Common Stock · 20,461 shares Expires 2020-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase 102,308 shares of common stock vesting in four equal annual installments beginning on February 16, 2011, the first anniversary of the grant. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
SaleCommon Stock | 92,158 | $27.48 | $2,532,068.70 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · nonDerivative · entry 8 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,960 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.29 to $27.58, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionCommon Stock | 6,093 | $6.28 | $38,264.04 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · nonDerivative · entry 7 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionCommon Stock | 7,572 | $7.39 | $55,957.08 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · nonDerivative · entry 6 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionCommon Stock | 12,422 | $7.16 | $88,941.52 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · nonDerivative · entry 5 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionCommon Stock | 13,661 | $13.08 | $178,685.88 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · nonDerivative · entry 4 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionCommon Stock | 15,086 | $16.31 | $246,052.66 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · nonDerivative · entry 3 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionCommon Stock | 16,863 | $17.26 | $291,055.38 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · nonDerivative · entry 2 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 20:08 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionCommon Stock | 20,461 | $7.41 | $151,616.01 |
DisclosureSEC source: 0001225208-17-012573 · doc4.xml · nonDerivative · entry 1 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 21:50 UTC |
Pratt Timothy A.EVP, GC & Chief Admin Officer
|
SaleCommon Stock | 10,000 | $27.87 | $278,653.00 |
DisclosureSEC source: 0001225208-17-012281 · doc4.xml · nonDerivative · entry 1 Pratt Timothy A. · CIK 0001432178 · EVP, GC & Chief Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,846 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.85 to $27.90, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 29, 2017 Filed Jun 29, 2017 21:15 UTC |
Phalen Michael P.EVP & President, MedSurg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,500 | $0.00 Strike: $7.16 | $0.00 |
DisclosureSEC source: 0001225208-17-011676 · doc4.xml · derivative · entry 3 Phalen Michael P. · CIK 0001483882 · EVP & President, MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,335 Underlying: Common Stock · 15,500 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant. Read SEC document |
| June 29, 2017 Filed Jun 29, 2017 21:15 UTC |
Phalen Michael P.EVP & President, MedSurg
|
SaleCommon Stock | 15,500 | $28.02 | $434,289.85 |
DisclosureSEC source: 0001225208-17-011676 · doc4.xml · nonDerivative · entry 2 Phalen Michael P. · CIK 0001483882 · EVP & President, MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,919 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.98 to $28.08, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| June 29, 2017 Filed Jun 29, 2017 21:15 UTC |
Phalen Michael P.EVP & President, MedSurg
|
Exercise / conversionCommon Stock | 15,500 | $7.16 | $110,980.00 |
DisclosureSEC source: 0001225208-17-011676 · doc4.xml · nonDerivative · entry 1 Phalen Michael P. · CIK 0001483882 · EVP & President, MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| June 16, 2017 Filed Jul 2, 2018 20:28 UTC |
Sununu John EDirector
|
PurchaseCommon Stock | 30 | $27.80 | $834.00 |
DisclosureSEC source: 0001225208-18-011026 · doc4.xml · nonDerivative · entry 2 Sununu John E · CIK 0001458974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,324 F1 · kind: These shares were acquired by, and held in, a managed account. F2 · balance_after: Reflects transactions that have taken place since the date of this transaction and which have been previously reported on Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.